Trials / Unknown
UnknownNCT04250220
eHealth-based Bavarian Alternative Detection of Atrial Fibrillation: A Randomized Controlled Trial (eBRAVE-AF)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4,400 (estimated)
- Sponsor
- LMU Klinikum · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Atrial fibrillation (AF) is the most common arrhythmia in western countries and causes of up to one quarter of ischemic strokes. The randomized eHealth-based Bavarian Alternative Detection of Atrial Fibrillation study (eBRAVE-AF) tests the efficacy of an e-health based strategy for the detection of AF. The e-health-based strategy consists of a smartphone-based photophlethysmographic (PPG) screening and an ECG-based validation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | e-Health based strategy: PPG-based screening using a smartphone and ECG patch | PPG-analysis via Smartphone-App (Preventicus Heart Beats) and ECG patch |
Timeline
- Start date
- 2020-02-03
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
- First posted
- 2020-01-31
- Last updated
- 2021-06-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04250220. Inclusion in this directory is not an endorsement.